Dynamic In Vitro Models for Antimicrobial Development
Author Information
Author(s): Wale Yalew M., Jason A. Roberts, Sime Fekade B.
Primary Institution: Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia
Hypothesis
Dynamic in vitro infection models can effectively simulate human-like pharmacokinetic profiles to optimize antimicrobial regimens.
Conclusion
Dynamic in vitro infection models replicate interactions between microorganisms and antimicrobial exposures, providing data that predict clinical efficacy.
Supporting Evidence
- Dynamic in vitro models provide reliable pharmacokinetic/pharmacodynamic data.
- These models help define initial dosing regimens for new antimicrobials.
- They are useful for optimizing dosing regimens for existing antimicrobials.
- Dynamic models can simulate human-like concentration-time profiles.
Takeaway
This study shows that special lab models can help scientists understand how medicines work against germs in our bodies, which can lead to better treatments.
Methodology
The review discusses various dynamic in vitro PK/PD infection models and their applications in optimizing antimicrobial treatment regimens.
Limitations
The review does not cover static models or animal models, which may limit the scope of the findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website